Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects
NCT ID: NCT05036629
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
600 participants
INTERVENTIONAL
2021-09-09
2026-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methodological Developments for Magnetic Resonance Imaging (MRI)
NCT02887053
Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers
NCT02790411
Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers
NCT02790424
Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects
NCT02900339
Validation and Implementation of 3T MRI Research Protocols
NCT04866940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI protocol
Feasibility and use of methods developed in clinical research protocols or cognitive: the reproducibility of the parameters of acquisition, of the design of the activation paradigms development and results according to people will be an important element for the future integration of these methods in clinical or cognitive research protocols.
MRI Protocol
Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse,
* NIRS Oxymon artinis medical system
* tES (transcranial electrical stimulation, Neuroelectrics)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI Protocol
Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse,
* NIRS Oxymon artinis medical system
* tES (transcranial electrical stimulation, Neuroelectrics)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants affiliated to a social security scheme or beneficiaries of such a scheme
* Participants with French as their mother tongue
* Participants who have given the signed informed consent before carrying out any procedure related to the study.
* Volunteer patients will be recruited as part of their follow-up at the CHU. Their pathology will be in agreement with that of the research protocol to be optimized.
Exclusion Criteria
* metallic glitter in the eyes
* retinal operation
* claustrophobia
* wearer of pacemaker or cardiac defribrillator or vascular clip or prosthesis cardiac or insulin pump or implanted device to deliver medication or hearing implant or prosthesis or vascular shunt or paragraph or screws, plate metal or tattoo or piercing or implanted metal object or lead shot hunt
* Alcohol ingestion before the examination
* Pregnant, lactating and parturient women
* Major protected by law
* Participants under administrative or judicial supervision
* Participation in another ongoing study if the study may interfere with participation in the protocol MAP-IRMaGe.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unité Mixte de Service IRMaGe US 017
La Tronche, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03555-34
Identifier Type: OTHER
Identifier Source: secondary_id
38RC20.395
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.